Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huibo Dai

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMC Women'S Health|June 29, 2026
Benign hemorrhagic mesenteric cyst mimicking peritoneal dissemination in early-stage ovarian clear cell carcinoma: a case reportXue Huang, Xingya Liu, Huibo Dai, et al.
Experimental and Therapeutic Medicine|January 23, 2023
Cimigenol depresses acute myeloid leukemia cells protected by breaking bone marrow stromal cells via CXCR4/SDF‑1αBangyun Ma, Huibo Dai, Xingbin Dai, et al.
Pharmaceutical Biology|May 21, 2020
Anti-angiogenic activity of ShengMaBieJia decoction <i>in vitro</i> and in acute myeloid leukaemia tumour-bearing mouse modelsMengya Wang, Bangyun Ma, Xingbin Dai, et al.
Frontiers in Physiology|February 23, 2024
Intercellular communication in peritoneal dialysisLi Sheng, Yun Shan, Huibo Dai, et al.
Scientific Reports|May 6, 2025
Genome-wide DNA methylation analysis of Astragalus on the intervention of ID2 promoter via PI3K/Akt signaling pathway in peritoneal fibrosisManshu Yu, Junyi Zhao, Yun Shan, et al.
Frontiers in Pharmacology|February 7, 2025
Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosisXiaohui Meng, Li Sheng, Yongqing You, et al.
Journal of Ethnopharmacology|July 12, 2023
Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosisHuibo Dai, Yun Shan, Manshu Yu, et al.
Frontiers in Oncology|November 26, 2020
Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-AnalysisShushu Qian, Hong Zhang, Huibo Dai, et al.
Frontiers in Pharmacology|September 6, 2024
Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathwayLi Sheng, Jinyi Sun, Liyan Huang, et al.
Journal of Ethnopharmacology|March 11, 2023
TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosisJinyi Sun, Lei Tang, Yun Shan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMC Women'S Health|June 29, 2026
Benign hemorrhagic mesenteric cyst mimicking peritoneal dissemination in early-stage ovarian clear cell carcinoma: a case reportXue Huang, Xingya Liu, Huibo Dai, et al.
Experimental and Therapeutic Medicine|January 23, 2023
Cimigenol depresses acute myeloid leukemia cells protected by breaking bone marrow stromal cells via CXCR4/SDF‑1αBangyun Ma, Huibo Dai, Xingbin Dai, et al.
Pharmaceutical Biology|May 21, 2020
Anti-angiogenic activity of ShengMaBieJia decoction <i>in vitro</i> and in acute myeloid leukaemia tumour-bearing mouse modelsMengya Wang, Bangyun Ma, Xingbin Dai, et al.
Frontiers in Physiology|February 23, 2024
Intercellular communication in peritoneal dialysisLi Sheng, Yun Shan, Huibo Dai, et al.
Scientific Reports|May 6, 2025
Genome-wide DNA methylation analysis of Astragalus on the intervention of ID2 promoter via PI3K/Akt signaling pathway in peritoneal fibrosisManshu Yu, Junyi Zhao, Yun Shan, et al.
Frontiers in Pharmacology|February 7, 2025
Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosisXiaohui Meng, Li Sheng, Yongqing You, et al.
Journal of Ethnopharmacology|July 12, 2023
Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosisHuibo Dai, Yun Shan, Manshu Yu, et al.
Frontiers in Oncology|November 26, 2020
Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-AnalysisShushu Qian, Hong Zhang, Huibo Dai, et al.
Frontiers in Pharmacology|September 6, 2024
Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathwayLi Sheng, Jinyi Sun, Liyan Huang, et al.
Journal of Ethnopharmacology|March 11, 2023
TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosisJinyi Sun, Lei Tang, Yun Shan, et al.
Pageof 2